UnitedHealth’s Optum Defends $3.3 Billion Acquisition of Amedisys Amid DOJ Lawsuit
DOJ Lawsuit:
The Department of Justice (DOJ) has filed a lawsuit to block UnitedHealth's Optum from acquiring Amedisys, a home health company, for $3.3 billion, citing antitrust concerns24.
Optum's Defense:
Optum is mounting a defense against the DOJ's lawsuit, arguing that the acquisition does not violate antitrust laws2.
Acquisition Details:
The deal is expected to close in the first quarter of 2025 if it proceeds3.
Antitrust Concerns:
The DOJ's lawsuit highlights concerns about the potential for reduced competition and increased market power in the home health sector if the acquisition is allowed to proceed24.
Contextual Background:
This development comes amidst broader scrutiny of healthcare conglomerates, including recent allegations against pharmacy benefit managers (PBMs) like Optum Rx for allegedly favoring affiliated pharmacies over independent ones1.
Sources:
1. https://finance.yahoo.com/news/pbm-executives-threatened-fines-jail-103100672.html?guccounter=2
2. https://www.fiercehealthcare.com/finance?page=1
3. https://www.healthcaredive.com/news/cigna-medicare-advantage-cuts-2025/727616/